Cells surviving infection by human immunodeficiency virus type 1: vif or vpu mutants produce non-infectious or markedly less cytopathic viruses.
Under conditions in which a clonal cell line (M10) isolated from a human T cell lymphotrophic virus type I-transformed MT-4 cell line was completely killed by infection with wild-type human immunodeficiency virus type 1 (HIV-1), equivalent M10 cells survived infection with HIV-1 vif, vpr or vpu mutant virus after transient cytopathic effects. Several cell clones, which were isolated from the proliferating M10 cells after infection with vif and vpu mutant viruses (M10/vif- and M10/vpu-), had heterogeneous HIV-1 phenotypes in terms of HIV-1 antigen expression, their syncytium forming capacity, reverse transcriptase activity and the infectivity of HIV-1 particles produced. When the replication kinetics of the HIV-1 particles produced were assayed in M10 cells, the clones could be classified into three types, i.e. type I producing non-infectious HIV-1, type II producing infectious HIV-1 with low replicative ability and type III producing infectious HIV-1 with a replicative ability similar to that of wild-type HIV-1. HIV-1 major viral cell proteins and virus particle fractions were almost typical in types II and III but not in type I. Electron microscopic examination of particles released by I, II and III clones revealed rare defective, predominantly defective and essentially normal virions, respectively. Northern and Southern blot analyses revealed no apparent deletion in the proviral DNA and mRNA prepared from these clones, except in the case of type I and II clones isolated from M10/vpu- which contained large deletions in the mRNAs for gag and gag-pol proteins. Thus, M10 cells surviving infection with HIV-1 vif or vpu mutants are heterogeneous, persistently expressing HIV-1 antigens and producing non-infectious or less cytopathic virus.
Kishi
M
M
Institute of Immunological Science, Hokkaido University, Sapporo, Japan.
Nishino
Y
Y
Sumiya
M
M
Ohki
K
K
Kimura
T
T
Goto
T
T
Nakai
M
M
Kakinuma
M
M
Ikuta
K
K
D015152:Blotting, Northern; D015139:Blotting, Southern; D002461:Cell Line, Transformed; D002470:Cell Survival; D003588:Cytopathogenic Effect, Viral / Q000235:genetics*; D004279:DNA, Viral / Q000737:chemistry / Q000235:genetics; D005455:Fluorescent Antibody Technique; D015686:Gene Products, env / Q000032:analysis; D015683:Gene Products, gag / Q000032:analysis; D016341:Genes, vif / Q000235:genetics*; D016338:Genes, vpu / Q000235:genetics*; D015497:HIV-1 / Q000235:genetics* / Q000472:pathogenicity / Q000502:physiology / Q000648:ultrastructure; D006801:Humans; D007700:Kinetics; D008854:Microscopy, Electron; D009154:Mutation / Q000235:genetics; D011533:Proviruses / Q000235:genetics; D012333:RNA, Messenger / Q000737:chemistry / Q000235:genetics; D012367:RNA, Viral / Q000737:chemistry / Q000235:genetics; D014779:Virus Replication
D004279:DNA, Viral; D015686:Gene Products, env; D015683:Gene Products, gag; D012333:RNA, Messenger; D012367:RNA, Viral